ConductScience.org, home

Paper42650751

Risk of Adverse Pregnancy Outcomes in Patients with Non-Communicable, Chronic Inflammatory Barrier Diseases Under Systemic Treatment: A Large-Scale Retrospective Cohort Study.

Brouer IC and 4 others. Biomolecules, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Risk of Adverse Pregnancy Outcomes in Patients with Non-Communicable, Chronic Inflammatory Barrier Diseases Under Systemic Treatment: A Large-Scale Retrospective Cohort Study. Papers, record 42650751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42650751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Risk of Adverse Pregnancy Outcomes in Patients with Non-Communicable, Chronic Inflammatory Barrier Diseases Under Systemic Treatment: A Large-Scale Retrospective Cohort Study.
PubMed
Journal
Biomolecules
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brouer ICInga Catharinahttps://orcid.org/0009-0002-6312-0651
2Zani AAida
3Curman PPhiliphttps://orcid.org/0000-0003-2051-8491
4Ludwig RJRalf J
5Thaçi DDiamanthttps://orcid.org/0000-0001-8513-550X

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pregnancy OutcomeMajor topic
Pregnancy ComplicationsMajor topic
Antirheumatic AgentsMajor topic
InflammationMajor topic
Humans
Female
Pregnancy
Retrospective Studies
Adult
Azathioprine
Interleukin-23
Methotrexate
Tumor Necrosis Factor Inhibitors

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137193038A global federated real-world data and analytics platform for research.JAMIA Open2023https://conductscience.org/library/papers/37193038PubMed
232118278
Maternal and neonatal outcomes associated with biologic exposure before and during pregnancy in women with inflammatory systemic diseases: a systematic review and meta-analysis of observational studies.
Rheumatology (Oxford)2020https://conductscience.org/library/papers/32118278PubMed
340372753Use of Biologics During Pregnancy Among Patients With Autoimmune Conditions.JAMA Netw Open2025https://conductscience.org/library/papers/40372753PubMed
431373768Mediation of Adverse Pregnancy Outcomes in Autoimmune Conditions by Pregnancy Complications: A Mediation Analysis of Autoimmune Conditions and Adverse Pregnancy Outcomes.Arthritis Care Res (Hoboken)2020https://conductscience.org/library/papers/31373768PubMed
538899437Changes in the prevalence of maternal chronic conditions during pregnancy: A nationwide age-period-cohort analysis.BJOG2025https://conductscience.org/library/papers/38899437PubMed
626559393Successful pregnancy outcome under prolonged ustekinumab treatment in a patient with Crohn's disease and paradoxical psoriasis.J Eur Acad Dermatol Venereol2016https://conductscience.org/library/papers/26559393PubMed
733227283Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease.Gastroenterology2021https://conductscience.org/library/papers/33227283PubMed
837033665IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis.Front Pharmacol2023https://conductscience.org/library/papers/37033665PubMed
939626647Biologics Use for Psoriasis during Pregnancy and Its Related Adverse Outcomes in Pregnant Women and Newborns: Findings from WHO Pharmacovigilance Study.Int Arch Allergy Immunol2025https://conductscience.org/library/papers/39626647PubMed
1023134993Treatment of severe psoriasis with ustekinumab during pregnancy.J Drugs Dermatol2012https://conductscience.org/library/papers/23134993PubMed
1112535207IL-12 completely blocks ultraviolet-induced secretion of tumor necrosis factor alpha from cultured skin fibroblasts and keratinocytes.J Invest Dermatol2003https://conductscience.org/library/papers/12535207PubMed
1239834709Global trends in immune mediated inflammatory diseases: Psoriasis, atopic dermatitis, multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis.JAAD Int2025https://conductscience.org/library/papers/39834709PubMed
1325378092Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis.Hum Exp Toxicol2015https://conductscience.org/library/papers/25378092PubMed
1434748293Ustekinumab Safety in Pregnancy: A Comprehensive Review.Arthritis Care Res (Hoboken)2023https://conductscience.org/library/papers/34748293PubMed
1534874264Pregnancy and Autoimmune Disease.Dtsch Arztebl Int2022https://conductscience.org/library/papers/34874264PubMed
1623752881Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease.Am J Gastroenterol2013https://conductscience.org/library/papers/23752881PubMed
1734581874[Current aspects of antirheumatic therapy in pregnancy planning, during pregnancy and breastfeeding].Z Rheumatol2021https://conductscience.org/library/papers/34581874PubMed
1837731935Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019.EClinicalMedicine2023https://conductscience.org/library/papers/37731935PubMed
1940129946A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX.Front Pharmacol2025https://conductscience.org/library/papers/40129946PubMed
2035014759Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta-analysis.BJOG2022https://conductscience.org/library/papers/35014759PubMed

See all 34 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42650751

GET https://conductscience.org/api/papers/v1/42650751/references?page=2